While tumor growth of HGFL-proficient tumors in HGFL-deficient mice was only modestly reduced, tumor characteristics including alterations to total/M1/M2 macrophage recruitment resembled our genetically engineered mouse models. The gene discussed is MST1; the disease is neoplasm.